Lumeda Selected as one of the 25 Technology Companies to Watch in the Greater Hartford Area
Summary
Lumeda Inc., a medical technology company focused on applying Photodynamic Therapy (PDT) as an adjuvant treatment for lung cancer patients, today announced it has been selected for inclusion in the Hartford Business Journal’s inaugural Tech 25. The list includes “companies to watch” from a wide range of industries that are making moves with new products, raising capital, or have a promising technology or drug that can generate revenue while also potentially saving lives and creating new jobs. “We are pleased to have been selected by HBJ to join an impressive lineup of companies as part of the inaugural Tech 25 class,” said Sandy Zinke, Lumeda CEO. PDT has been shown to significantly improve patient progression-free and overall survival when applied intraoperatively following surgical lung cancer tumor resection. The multidisciplinary Lumeda team has decades of experience in the photonics industry, with expertise in systems engineering and commercialization of new medical technology.